NM_005199.5:c.921-12C>T

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_005199.5(CHRNG):​c.921-12C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.27 in 1,566,898 control chromosomes in the GnomAD database, including 61,471 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.24 ( 5087 hom., cov: 32)
Exomes 𝑓: 0.27 ( 56384 hom. )

Consequence

CHRNG
NM_005199.5 intron

Scores

2
Splicing: ADA: 0.00009861
2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: -0.773

Publications

10 publications found
Variant links:
Genes affected
CHRNG (HGNC:1967): (cholinergic receptor nicotinic gamma subunit) The mammalian muscle-type acetylcholine receptor is a transmembrane pentameric glycoprotein with two alpha subunits, one beta, one delta, and one epsilon (in adult skeletal muscle) or gamma (in fetal and denervated muscle) subunit. This gene, which encodes the gamma subunit, is expressed prior to the thirty-third week of gestation in humans. The gamma subunit of the acetylcholine receptor plays a role in neuromuscular organogenesis and ligand binding and disruption of gamma subunit expression prevents the correct localization of the receptor in cell membranes. Mutations in this gene cause Escobar syndrome and a lethal form of multiple pterygium syndrome. Muscle-type acetylcholine receptor is the major antigen in the autoimmune disease myasthenia gravis.[provided by RefSeq, Sep 2009]
CHRNG Gene-Disease associations (from GenCC):
  • autosomal recessive multiple pterygium syndrome
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Ambry Genetics, G2P, Orphanet
  • CHRNG-associated hypo-akinesia disorder of prenatal onset
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • lethal multiple pterygium syndrome
    Inheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: PanelApp Australia, Labcorp Genetics (formerly Invitae), Orphanet
  • transient neonatal myasthenia gravis
    Inheritance: AR Classification: STRONG Submitted by: Genomics England PanelApp

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.62).
BP6
Variant 2-232543573-C-T is Benign according to our data. Variant chr2-232543573-C-T is described in ClinVar as Benign. ClinVar VariationId is 259670.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.401 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CHRNGNM_005199.5 linkc.921-12C>T intron_variant Intron 8 of 11 ENST00000651502.1 NP_005190.4 P07510-1A0A6F7YAP6

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CHRNGENST00000651502.1 linkc.921-12C>T intron_variant Intron 8 of 11 NM_005199.5 ENSP00000498757.1 P07510-1
CHRNGENST00000389492.3 linkc.765-12C>T intron_variant Intron 7 of 10 1 ENSP00000374143.3 P07510-2

Frequencies

GnomAD3 genomes
AF:
0.239
AC:
36277
AN:
151910
Hom.:
5065
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.115
Gnomad AMI
AF:
0.277
Gnomad AMR
AF:
0.361
Gnomad ASJ
AF:
0.333
Gnomad EAS
AF:
0.416
Gnomad SAS
AF:
0.378
Gnomad FIN
AF:
0.230
Gnomad MID
AF:
0.318
Gnomad NFE
AF:
0.259
Gnomad OTH
AF:
0.260
GnomAD2 exomes
AF:
0.309
AC:
76913
AN:
248804
AF XY:
0.311
show subpopulations
Gnomad AFR exome
AF:
0.109
Gnomad AMR exome
AF:
0.474
Gnomad ASJ exome
AF:
0.341
Gnomad EAS exome
AF:
0.443
Gnomad FIN exome
AF:
0.232
Gnomad NFE exome
AF:
0.261
Gnomad OTH exome
AF:
0.299
GnomAD4 exome
AF:
0.274
AC:
387189
AN:
1414870
Hom.:
56384
Cov.:
26
AF XY:
0.277
AC XY:
195936
AN XY:
706378
show subpopulations
African (AFR)
AF:
0.101
AC:
3300
AN:
32584
American (AMR)
AF:
0.464
AC:
20594
AN:
44390
Ashkenazi Jewish (ASJ)
AF:
0.343
AC:
8864
AN:
25864
East Asian (EAS)
AF:
0.446
AC:
17593
AN:
39454
South Asian (SAS)
AF:
0.378
AC:
32202
AN:
85206
European-Finnish (FIN)
AF:
0.230
AC:
12243
AN:
53242
Middle Eastern (MID)
AF:
0.277
AC:
1573
AN:
5678
European-Non Finnish (NFE)
AF:
0.256
AC:
274296
AN:
1069604
Other (OTH)
AF:
0.281
AC:
16524
AN:
58848
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
15715
31430
47146
62861
78576
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
9314
18628
27942
37256
46570
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.239
AC:
36321
AN:
152028
Hom.:
5087
Cov.:
32
AF XY:
0.244
AC XY:
18092
AN XY:
74282
show subpopulations
African (AFR)
AF:
0.114
AC:
4749
AN:
41478
American (AMR)
AF:
0.362
AC:
5543
AN:
15292
Ashkenazi Jewish (ASJ)
AF:
0.333
AC:
1156
AN:
3468
East Asian (EAS)
AF:
0.416
AC:
2128
AN:
5116
South Asian (SAS)
AF:
0.379
AC:
1825
AN:
4820
European-Finnish (FIN)
AF:
0.230
AC:
2430
AN:
10572
Middle Eastern (MID)
AF:
0.336
AC:
98
AN:
292
European-Non Finnish (NFE)
AF:
0.259
AC:
17577
AN:
67968
Other (OTH)
AF:
0.266
AC:
562
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.498
Heterozygous variant carriers
0
1326
2651
3977
5302
6628
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
376
752
1128
1504
1880
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.241
Hom.:
3480
Bravo
AF:
0.248
Asia WGS
AF:
0.436
AC:
1513
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
Oct 21, 2019
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jan 27, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Autosomal recessive multiple pterygium syndrome Benign:1
Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Lethal multiple pterygium syndrome Benign:1
Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.62
CADD
Benign
3.5
DANN
Benign
0.81
PhyloP100
-0.77
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.000099
dbscSNV1_RF
Benign
0.044
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs13018423; hg19: chr2-233408283; COSMIC: COSV67315333; COSMIC: COSV67315333; API